[Federal Register Volume 68, Number 159 (Monday, August 18, 2003)]
[Notices]
[Page 49522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-21044]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 11, 2003, and published in the Federal 
Register on April 2, 2003, (68 FR 16091), Novartis Pharmaceuticals 
Corporation, Attn: Security Department, Building 103, Room 335, 59 
Route 10, East Hanover, New Jersey 07936, made application by renewal 
to the Drug Enforcement Administration to be registered as a bulk 
manufacturer of the basic class of controlled substance listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methylphenidate (1724).....................  II
------------------------------------------------------------------------

    The firm plans to produce bulk product and finished dosage units 
for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Novartis Pharmaceuticals 
Corporation to manufacture the listed controlled substance is 
consistent with the public interest at this time. DEA has investigated 
Novartis Pharmaceuticals Corporation to ensure that the company's 
registration is consistent with the public interest. This investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic class of controlled substance listed is 
granted.

    Dated: July 30, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-21044 Filed 8-15-03; 8:45 am]
BILLING CODE 4410-09-M